Neogenomics (NEO) Liabilities from Discontinued Operations (2025)
Neogenomics (NEO) posted Liabilities from Discontinued Operations of 478000.0 for Q3 2025, up 4.82% quarter-over-quarter from 456000.0 in Q2 2025.
Neogenomics (NEO) Liabilities from Discontinued Operations (2025) Analysis & Trends
Neogenomics (NEO) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 478000.0 the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 478,000.00 |
| Sep 30, 2025 | 478,000.00 |
| Jun 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 456,000.00 |